友霖 (4166)
友霖 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$148.83M, up 41.2% from a year earlier. EPS over the last four quarters totals NT$0.99.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2025-08-21
- Founded
- 2008-02-01
- Paid-in capital
- NT$2.43B
- Common shares issued
- 243,035,089
- Legal name
- 友霖生技醫藥股份有限公司
- Website
- https://academy.oppharma.com/
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$148.83M | +28.4% | +41.2% |
| 2026-08 | NT$115.92M | -12.1% | +14.9% |
Year to date: +20.5% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 0.24 |
| 2026 Q1 | 0.16 |
| 2025 Q4 | 0.38 |
| 2025 Q3 | 0.21 |
| 2025 Q2 | 0.08 |
| 2025 Q1 | 0.23 |
Last four quarters: NT$0.99
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 442 | 0.0% |
| 1,000–5,000 shares | 2,281 | 1.7% |
| 5,001–10,000 shares | 369 | 1.2% |
| 10,001–15,000 shares | 155 | 0.8% |
| 15,001–20,000 shares | 100 | 0.8% |
| 20,001–30,000 shares | 90 | 0.9% |
| 30,001–40,000 shares | 57 | 0.8% |
| 40,001–50,000 shares | 49 | 0.9% |
| 50,001–100,000 shares | 99 | 3.0% |
| 100,001–200,000 shares | 43 | 2.4% |
| 200,001–400,000 shares | 37 | 4.2% |
| 400,001–600,000 shares | 6 | 1.1% |
| 600,001–800,000 shares | 3 | 0.8% |
| 800,001–1,000,000 shares | 3 | 1.1% |
| 1,000,001+ shares | 15 | 80.0% |
TDCC data for 2026-10-16: 15 holders own more than 1,000 lots (80.0% of shares), and 442 hold less than one lot (0.0%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -4 | 0 | 0 | -4 |
| 2026-10-16 | 11 | 0 | 0 | 11 |
| 2026-10-15 | 14 | 0 | 0 | 14 |
| 2026-10-14 | -9 | 0 | 0 | -9 |
| 2026-10-13 | 2 | 0 | 0 | 2 |
| 2026-10-12 | 2 | 0 | 0 | 2 |
| 2026-10-08 | 22 | 0 | 0 | 22 |
| 2026-10-07 | 8 | 0 | 0 | 8 |
| 2026-10-06 | 17 | 0 | 0 | 17 |
| 2026-10-05 | -14 | 0 | 0 | -14 |
| 2026-10-02 | -4 | 0 | 0 | -4 |
| 2026-10-01 | 42 | 0 | 0 | 42 |
| 2026-09-30 | 4 | 0 | 0 | 4 |
| 2026-09-29 | -3 | 0 | 0 | -3 |
| 2026-09-24 | -39 | 0 | 0 | -39 |
| 2026-09-23 | -12 | 0 | 0 | -12 |
| 2026-09-22 | 18 | 0 | 0 | 18 |
| 2026-09-21 | -5 | 0 | 0 | -5 |
| 2026-09-18 | -4 | 0 | 0 | -4 |
| 2026-09-17 | 32 | 0 | 0 | 32 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 78 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$24.15 (2026-10-19); 52-week range NT$22.40–29.60.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.